Markus Perl
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Glycosylation and Glycoproteins Research 2
-
- Hematopoietic Stem Cell Transplantation 4
- Acute Myeloid Leukemia Research 1
- Co-authors
- Klaus‐Peter Janssen (3 shared papers)Ulrich Nitsche (2 shared papers)Ludger Johannes (2 shared papers)Elisa Benedetti (1 shared paper)Andrej Shevchenko (1 shared paper)Johannes Plagge (1 shared paper)Alida Kindt (1 shared paper)Marcus Höring (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Aesthetic Plastic Surgery (1 paper)Bone Marrow Transplantation (1 paper)Analytical Chemistry (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Markus Perl
11 papers receiving 213 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 60
- Endocrinology 12
- Biochemistry 14
- Molecular Biology 130
- Spectroscopy 26
Countries citing papers authored by Markus Perl
This map shows the geographic impact of Markus Perl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Perl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Perl more than expected).
Fields of papers citing papers by Markus Perl
This network shows the impact of papers produced by Markus Perl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Perl. The network helps show where Markus Perl may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Perl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 96 | |
| 2 | 2016 | 45 | |
| 3 | 2020 | 36 | |
| 4 | 2025 | 12 | |
| 5 | 2024 | 7 | |
| 6 | 2025 | 6 | |
| 7 | 2020 | 5 | |
| 8 | 2023 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2024 | 0 |
About Markus Perl
Markus Perl is a scholar working on Molecular Biology, Hematology, Oncology, Public Health, Environmental and Occupational Health and Transplantation, having authored 12 papers that have together received 214 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Ethics and Legal Issues in Pediatric Healthcare (1 paper), Cutaneous Melanoma Detection and Management (1 paper), Bacterial Genetics and Biotechnology (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Cancer Research (60 citations), Endocrinology (12 citations), Biochemistry (14 citations), Molecular Biology (130 citations) and Spectroscopy (26 citations). Markus Perl has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Klaus‐Peter Janssen, Ulrich Nitsche, Ludger Johannes, Elisa Benedetti, Andrej Shevchenko, Johannes Plagge, Alida Kindt, Marcus Höring, Jan Krumsiek and Yuting Wang. Their work appears in journals such as Molecular Cancer Therapeutics, Aesthetic Plastic Surgery, Bone Marrow Transplantation, Analytical Chemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.